Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

CTP-543 significantly improved eyebrow and eyelash regrowth and patient satisfaction in adults with alopecia areata.

Finasteride poorly inhibits type 1 5AR, affecting its effectiveness.

ODC1 gene mutations cause a neurodevelopmental disorder with large head size, hair loss, and facial abnormalities.

The L457(3.43)R mutation in the human lutropin receptor causes increased activity and hormone insensitivity, leading to precocious puberty.

Reduced androgens linked to kinky hair disorder and hair loss; 5a-reductase inhibitors may help.

People with PCNT mutations often develop severe insulin resistance and early-onset diabetes during childhood or adolescence.

A new genetic mutation was found causing hair and eye issues in a boy.

A mutation in the Soat1 gene causes hair structure defects and other health issues in AKR/J mice.

ATP-sensitive potassium channels are important for hair growth.

High levels of ODC and a mutant Ha-ras gene cause tumors in mice.

Enzymes called 5α-reductases have many body functions and need more research to safely use inhibitors.

dAR-6–1 is a promising new treatment for hair loss that works better than minoxidil.

People with hair loss have more androgen receptors and enzymes in certain follicles, with men and women showing different patterns.

Ritlecitinib reduces alopecia areata symptoms by blocking JAK3/TEC signaling and T-cell activity.

Eclipta alba flavonoids may help treat diabetes by effectively inhibiting Aldose reductase.

Hair sensitivity to androgens is partly controlled by specific enzyme expressions in different hair areas.

Female mice with disrupted 5α-reductase 1 had significant metabolic issues, including stress response problems, insulin resistance, liver fat buildup, and obesity.

A 2-year-old girl with a rare vitamin D disorder had rickets and hair loss, but treatment was ineffective due to poor compliance.

Ritlecitinib is being tested for safety and effectiveness in young children with severe alopecia areata.

A genetic mutation caused severe rickets and alopecia in an Indian patient, but high-dose calcium and phosphate treatment improved their condition.

Rapamycin treatment helps with mitochondrial disease by reducing PKC levels.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Different animals have unique versions of the enzyme that changes testosterone into another hormone, which is important for creating effective treatments for prostate and hair loss conditions.

Derinat helps extend hair growth by reducing harmful molecules in skin cells.

Synthetic hormone treatment reduces melanin and hair growth in rats.

Changing protein kinase levels in pituitary cells affects calcium flow and beta-endorphin release.

No consistent link between genotype and phenotype in 5-α-Reductase type 2 deficiency.

The girl had a rare disorder causing mental and physical symptoms, with weak hair and unclear neurological issues.

5 Alpha-Reductase Inhibitors reduce the effects of testosterone by blocking its conversion into a stronger form.

Cyanidin 3-O-arabinoside may help treat a common form of hair loss by protecting cells against aging and improving cell function.